Last reviewed · How we verify

NCT06963437

Interventions for Weight Regain After Bariatric Surgery

Completed NA Last updated 1 August 2025
What this trial tests

NA trial testing Diet in Obese Patients With Bariatric Surgery in 43 participants. Completed in 10 July 2025.

Timeline
12 May 2025
Primary endpoint
10 July 2025
10 July 2025

Quick facts

Lead sponsorMedipol University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment43
Start date12 May 2025
Primary completion10 July 2025
Estimated completion10 July 2025
Sites2 locations across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Medipol University

Who can join

Adults 18 to 45, any sex, with Obese Patients With Bariatric Surgery or Obese Patients (BMI ≥ 30 kg/m²). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Study Objective: The aim of this study is to evaluate the effects of revisional bariatric surgery (RBS), very low-calorie ketogenic diet (VLCKD), and intermittent fasting (IF) on nutritional habits and clinical outcomes (anthropometric and biochemical measurements) in patients with insufficient weight loss (IWL) or weight regain (WR) after bariatric surgery, and to compare these findings with those of a control group.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Diet

Trials testing the same drug.

Other recruiting trials for Obese Patients With Bariatric Surgery

Currently open trials in the same condition.

Other Medipol University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06963437.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing